Introduction
Pharmaceutical distribution in the UK is built on a strict regulatory structure designed to protect patient safety and product integrity. Two terms sit at the centre of this structure and are often mentioned together, the WDA license and Good Distribution Practice, commonly known …
Introduction
Applying for a WDA license is a significant step for any business involved in the wholesale supply of medicinal products in the UK. While the application process is clearly defined by the Medicines and Healthcare products Regulatory Agency, rejection rates remain higher than many …
Introduction
Applying for a WDA license in the UK is a structured regulatory process that requires preparation, clarity, and ongoing commitment to compliance. Many businesses underestimate what is involved, assuming the application is a simple administrative task. In reality, the Medicines and…
Introduction
If your business handles medicines anywhere between the manufacturer and the pharmacy shelf, regulatory approval is not optional. In the United Kingdom, the WDA license sits at the centre of lawful wholesale distribution. Many organisations misunderstand its scope, assume it only …
The FDA published a recall notice in October 2024 for 1 lot of Ascorbic Acid Solution for Injection vials to the user level due to glass particles in vial.
In some cases, glass particles can pass through the needle and may result in local irritation or swelling. The particulate matter could tr…
Computerised systems play an essential role in regulated environments. Pharmaceutical manufacturers, biotech organisations, laboratories, medical device companies and clinical research teams rely on digital platforms to produce, store or process data that influences patient safety and product qu…
We use cookies to improve user experience and analyse website traffic. By clicking “Accept“, you agree to our website's cookie use as described in our Cookie Policy.